Comparison of the efficacy and safety of neoadjuvant PD-1 inhibitors plus chemotherapy vs targeted therapy plus chemotherapy in locally advanced hypopharyngeal squamous cell carcinoma (LA HPSCC)
第一作者机构：[1]Capital Med Univ, Beijing Tongren Hosp, Dept Otorhinolaryngol Head & Neck Surg, Beijing, Peoples R China
推荐引用方式(GB/T 7714)：
Zhang Y.,Gao W.,Feng L.,et al.Comparison of the efficacy and safety of neoadjuvant PD-1 inhibitors plus chemotherapy vs targeted therapy plus chemotherapy in locally advanced hypopharyngeal squamous cell carcinoma (LA HPSCC)[J].ANNALS OF ONCOLOGY.2024,35:doi:10.1016/j.annonc.2024.10.462.
APA：
Zhang, Y.,Gao, W.,Feng, L.,Zhao, X.,Huang, Z....&Z. Huang.(2024).Comparison of the efficacy and safety of neoadjuvant PD-1 inhibitors plus chemotherapy vs targeted therapy plus chemotherapy in locally advanced hypopharyngeal squamous cell carcinoma (LA HPSCC).ANNALS OF ONCOLOGY,35,
MLA：
Zhang, Y.,et al."Comparison of the efficacy and safety of neoadjuvant PD-1 inhibitors plus chemotherapy vs targeted therapy plus chemotherapy in locally advanced hypopharyngeal squamous cell carcinoma (LA HPSCC)".ANNALS OF ONCOLOGY 35.(2024)
医学